P. Keating

发表

Development of an ELISA-Based Competitive Binding Assay for the Analysis of Drug Concentration and Antidrug Antibody Levels in Patients Receiving Adalimumab or Infliximab

M. Barclay, L. Stamp, B. Hock, 2016, Therapeutic drug monitoring.

Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis

J. Orian, M. Hale, Hong Pham, 2015, Autoimmunity.

Infliximab and adalimumab concentrations and anti‐drug antibodies in inflammatory bowel disease control using New Zealand assays

M. Schultz, M. Barclay, L. Stamp, 2019, Internal medicine journal.

Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab- and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution Assay

B. Hock, J. McKenzie, Liping Goddard, 2018, Therapeutic drug monitoring.

Protection from EAE by IL‐4Rα−/− macrophages depends upon T regulatory cell involvement

F. Brombacher, A. L. La Flamme, D. Kenwright, 2009, Immunology and cell biology.

Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serum.

B. Hock, J. McKenzie, Stewart M. Smith, 2019, Journal of immunological methods.

Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.

J. Neil, O. Jarrett, J. Beatty, 1996, Journal of immunology.

Patterns of major histocompatibility complex class II expression on T cell subsets in different immunological compartments 1. Expression on resting T cells

B. Dutia, J. Hopkins, I. Mcconnell, 1993, European journal of immunology.

HMGCR autoantibody testing: two tiers required.

K. Chow, M. Spellerberg, P. Keating, 2021, Pathology (Sydney).

Anti‐HMGCR autoantibodies in self‐limiting statin‐induced myopathy

C. Florkowski, J. Young, P. George, 2017, International journal of rheumatic diseases.

A distinctive staining pattern with anti-3-hydroxy-3-methyl-glutaryl-coenzyme a reductase (HMGCR) antibodies on mouse kidney.

M. Spellerberg, P. Keating, C. Allan, 2021, Pathology.

Response to: New immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis.

P. Keating, John Liu, J. O’Donnell, 2018, Pathology.

HMGCR‐associated myositis: a New Zealand case series and estimate of incidence

J. O'donnell, P. Keating, N. Kennedy, 2016, Internal medicine journal.

Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case study.

K. Chow, P. Keating, J. O’Donnell, 2022, Pathology.